Co-author Dr. David Fisman, of the University of Toronto's Dalla Lana school of public health, said the message of the study is that the choice to get vaccinated can't be thought of as merely personal.
The new regulations, which govern the Patented Medicine Prices Review Board, will lower pharmaceutical industry profits by $2.9 billion over a decade, rather than the $8.8 billion anticipated previously.
The PromoVac strategy, developed in Sherbrooke by Dr. Arnaud Gagneur to convince parents who are hesitant about vaccination, will be deployed across Canada through a telehealth platform.
Scientists have analyzed the full genetic blueprints of more than 18,000 cancer samples, finding new patterns of mutations that could help doctors provide better, more personalized treatment.
A new U.S. government center aims to become the National Weather Service for infectious diseases—an early warning system to help guide the response to COVID-19 and future pandemics.
Today's COVID-19 vaccines all are based on the original version of the coronavirus. But the virus continues to mutate, with the super-contagious Omicron variant—and its siblings—the latest threat.
